Quantitative KRAS mutational burden by next-generation sequencing predicts outcomes in localized pancreatic cancer. Sridalla K, Machhi JK, Vitello DJ, Cox M, et al. Surgery 2026;196:110303.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sridalla K, Machhi JK, Vitello DJ, Cox M, et al. Quantitative KRAS mutational burden by next-generation sequencing predicts outcomes in localized pancreatic cancer. Surgery 2026;196:110303.
PMID: 42263374